Cited by 742Cardiac Ischemia and ReperfusionMetabolism, Diabetes, and CancerCardiovascular Function and Risk Factors

AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

Open access
Russell, Raymond R., Li, Ji, Coven, David L., Pypaert, Marc, Zechner, Christoph, Palmeri, Monica, Giordano, Frank J., Mu, James +2 more·2004·Journal of Clinical Investigation

Abstract

AMP-activated protein kinase (AMPK) is an important regulator of diverse cellular pathways in the setting of energetic stress.Whether AMPK plays a critical role in the metabolic and functional responses to myocardial ischemia and reperfusion remains uncertain.We examined the cardiac consequences of long-term inhibition of AMPK activity in transgenic mice expressing a kinase dead (KD) form of the enzyme.The KD mice had normal fractional shortening and no heart failure, cardiac hypertrophy, or fibrosis, although the in vivo left ventricular (LV) dP/dt was lower than that in WT hearts.During low-flow ischemia and postischemic reperfusion in vitro, KD hearts failed to augment glucose uptake and glycolysis, although glucose transporter content and insulin-stimulated glucose uptake were normal.KD hearts also failed to increase fatty acid oxidation during reperfusion.Furthermore, KD hearts demonstrated significantly impaired recovery of LV contractile function during postischemic reperfusion that was associated with a lower ATP content and increased injury compared with WT hearts.Caspase-3 activity and TUNEL-staining were increased in KD hearts after ischemia and reperfusion.Thus, AMPK is responsible for activation of glucose uptake and glycolysis during low-flow ischemia and plays an important protective role in limiting damage and apoptotic activity associated with ischemia and reperfusion in the heart.Nonstandard abbreviations used: acetyl-CoA carboxylase (ACC); 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR); AMP-activated protein kinase (AMPK); carnitine palmitoyltransferase-1 (CPT-1); kinase dead (KD); left ventricular (LV); LV developed pressure (LVDP); 6-phosphofructo-2-kinase (PFK-2). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci19297

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMPK decreased apoptosis, improved post-ischemic recovery, and limited myocardial infarction.

    “Mechanically, AMPK increased glucose uptake and glucose transporter 4 translocation [171], decreased apoptosis, improved post-ischemic recovery, and limited myocardial infarction (MI) [172,173].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [173]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Russell, R. R., Li, J., Coven, D. L., Pypaert, M., Zechner, C., Palmeri, M., Giordano, F. J., Mu, J., Birnbaum, M. J., & Young, L. H.
Affiliations
  • Yale University (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Young, Lawrence H.
Venue
Journal of Clinical Investigation
Published
2004-08-16
Volume
114
Issue
4
Pages
495-503
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2073534977
Cited by
738
References
74
Citations by year
2026: 10 · 2025: 16 · 2024: 16 · 2023: 19 · 2022: 28 · 2021: 30 · 2020: 23 · 2019: 26 · 2018: 28 · 2017: 31 · 2016: 40 · 2015: 36 · 2014: 42 · 2013: 34 · 2012: 52
FWCI
24.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • American Heart Association
  • Yale University
  • Deutscher Akademischer Austauschdienst
  • Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University
  • U.S. Public Health Service (U24 DK59635)
  • National Heart, Lung, and Blood Institute (R01HL063811, R01-HL-63811, HL 10301, F32HL010301)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK59635, U24DK059635)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
AMPK, myocardial ischemia, ischemia-reperfusion injury, glucose uptake, glycolysis, cardiac contractile function, apoptosis, caspase-3, fatty acid oxidation, ATP levels, cardioprotection, energy metabolism
MeSH terms
Animals, Glucose, Glycolysis, Mice, Inbred C57BL, Mice, Transgenic, Multienzyme Complexes, Myocardial Reperfusion Injury, Myocardial Ischemia, Apoptosis, Protein Serine-Threonine Kinases, Mice, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review